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Incidence of neurologic manifestations associated with Zika 
virus infection has been increasing. In 2016, neuropsycho-
logical and cognitive changes developed in an adolescent 
after travel to a Zika virus–endemic area. Single-photon 
emission computed tomography and neuropsychological 
testing raised the possibility that Zika virus infection may 
lead to neuropsychiatric and cognitive symptoms.
Although the full clinical spectrum of complications as-sociated with Zika virus disease remains unclear, evi-
dence of an association between Zika virus infection and 
diseases of the nervous system is growing (1). Increased 
incidence of neurologic manifestations has been reported, 
including cerebral birth abnormalities (2), Guillain-Barré 
Syndrome (3), meningoencephalitis (4), and memory loss 
(5). We describe a case of probable central nervous system 
(CNS) infection with Zika virus associated with the onset of 
neuropsychological and cognitive changes in an adolescent. 
In summer 2016, an adolescent traveled to a Zika vi-
rus–endemic island in the southern Caribbean, where many 
insect bites occurred. Before the trip, the patient’s medical 
history included mild depression treated with a selective 
serotonin reuptake inhibitor. Assessment after return to 
the United States indicated that mental and physical health 
were the same as before travel. One week after return, the 
patient experienced sore throat, headache, diffuse scarlati-
niform rash (online Technical Appendix Figure 1, https://
wwwnc.cdc.gov/EID/article/23/6/16-2029-Techapp1.pdf), 
joint pain, confusion, and short-term memory loss; no fever 
or eye inflammation were noted.
Three days after symptom onset, the patient received 
care from a pediatrician; extensive laboratory testing re-
vealed urine reverse transcription PCR (RT-PCR) results 
positive for Zika virus. Serologic results were positive 
for Epstein-Barr virus, consistent with the patient’s his-
tory of infection 15 months earlier (online Technical Ap-
pendix Table 1). Five days after symptom onset, the sore 
throat, headache, rash and joint pain resolved; however, 8 
days after symptom onset, the neuropsychiatric symptoms 
worsened and included excessive energy, decreased sleep, 
rapid and tangential speech, grandiose thinking, impulsiv-
ity, decreased inhibition, and behavioral regression sugges-
tive of hypomania. The patient’s psychiatrist prescribed an 
antipsychotic medication. An ambulatory and 24-hour elec-
troencephalogram and magnetic resonance imaging of the 
brain without contrast showed no abnormalities.
Symptoms failed to improve, and 13 days after symp-
tom onset, the patient was hospitalized for further work-up. 
Fourteen days after symptom onset, magnetic resonance 
imaging of the brain with contrast showed no abnormali-
ties. Serum was positive for dengue virus IgG and IgM (on-
line Technical Appendix Table 2). Repeat Zika virus testing 
was not performed because of the prior positivity of urine 
RT-PCR. Fifteen days after symptom onset, cerebrospinal 
fluid (CSF) obtained by lumbar puncture contained 8 leu-
kocytes/μL, 1,000 erythrocytes/μL, 55 mg/dL glucose, and 
30 mg/dL protein. CSF testing for Zika virus, performed 
at the Wadsworth Laboratory, New York City Department 
of Mental Health and Hygiene (New York, NY, USA), was 
positive for IgM but negative by RT-PCR.
After discharge, the patient’s symptoms of regres-
sion, disinhibition, and cognitive impairment persisted. 
Seven weeks after symptom onset, single-photon emis-
sion computed tomography revealed mildly heteroge-
neous cerebral cortical perfusion, with focal moderate-
to-severe hypoperfusion in the inferior left frontal region 
(online Technical Appendix Figure 2); neuropsychologi-
cal testing demonstrated evidence of superior intellectual 
ability (Wechsler Intelligence Scale for Children–fourth 
edition, General Ability Index), probably reflecting func-
tion before illness (online Technical Appendix Table 3). 
Processing speed was significantly slowed relative to oth-
er skills; the Processing Speed Index score was >2 SDs 
lower than the General Ability Index score. Performance 
on most memory tests and tests of executive function 
was within normal limits yet lower than expected given 
reported performance before illness. Immediate and de-
layed visual recall of the Rey complex figure was poor, 
reflecting primary difficulty encoding new visual infor-
mation. On a standardized behavioral questionnaire, the 
patient self-reported psychiatric symptoms including anx-
iety, racing thoughts, and an inability to turn off thoughts. 
The patient had not experienced racing thoughts before 
the Zika virus infection, and the anxiety symptoms had 
worsened since the infection. In addition, the patient re-
ported significant and functionally limiting fatigue. Nine 
weeks after onset, symptoms were better but not resolved; 
because of concerns that these symptoms were triggered 
by a postinfectious immune-mediated process, a trial of 
intravenous immunoglobulin was administered. Fifteen 
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weeks after symptom onset, the patient’s symptoms were 
better but not fully resolved.
Although we cannot entirely rule out Epstein-Barr vi-
rus as a possible trigger, the length of time between previous 
infection and onset of neuropsychological symptoms would 
be unusual. In addition, although it is impossible to exclude 
contributions of coinfection from other mosquitoborne vi-
ruses (e.g., dengue and chikungunya), given the Zika virus 
positivity on RT-PCR, the patient’s condition met criteria 
for definitive Zika virus infection and the CSF IgM titer was 
consistent with CNS involvement of Zika virus. The changes 
on single-photon emission computed tomographs and neuro-
psychological test scores raise the possibility that Zika virus 
infection may trigger neuropsychiatric and cognitive symp-
toms. Although we cannot prove that the patient’s symptoms 
were related to Zika virus, clinicians should be aware of this 
potential association and the value of closely monitoring pa-
tients with Zika virus infection.
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We isolated highly pathogenic avian influenza virus (H5N8) 
of clade 2.3.4.4 from the common coot (Fulica atra) in 
Egypt, documenting its introduction into Africa through mi-
gratory birds. This virus has a close genetic relationship 
with subtype H5N8 viruses circulating in Europe. Enhanced 
surveillance to detect newly emerging viruses is warranted.
Avian influenza is a highly contagious disease of poul-try that continues to spread across the globe in bird 
populations. Occasionally, transmission of a highly patho-
genic avian influenza virus (HPAIV) from infected poultry 
to humans results in a severe public health crisis (1).
In 2010, strains of HPAIV (H5N8) of clade 2.3.4.4 
were first detected among wild birds in Asia and later 
spread to domestic birds across China, South Korea, and 
Japan (2,3). Most recently, a novel reassortant virus of sub-
type H5N8 clade 2.3.4.4 was reported in Russia and further 
spread to many countries in Europe, Asia, and the Middle 
East (4,5). The spread of HPAIV (H5N8) strains has been 
linked to the overlapping flyways of migratory wild birds 
that come from different continents; this mingling of wild 
birds poses a major concern worldwide (4,6).
Egypt is one of the most notable migration spots for 
migratory birds crossing Europe, Asia, and Africa. In early 
winter each year, thousands of migrating waterfowl use 
Egypt as a resting stop before they continue their journey 
southward through the African continent through the East 
Africa/East Asia and Mediterranean/Black Sea migratory 
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